• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向耐药菌株毒力特性的合成及半合成抗菌化合物:一篇叙述性更新综述

Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review.

作者信息

Stojković Dejan, Petrović Jovana, Carević Tamara, Soković Marina, Liaras Konstantinos

机构信息

Department of Plant Physiology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia.

Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, 2417 Nicosia, Cyprus.

出版信息

Antibiotics (Basel). 2023 May 25;12(6):963. doi: 10.3390/antibiotics12060963.

DOI:10.3390/antibiotics12060963
PMID:37370282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10295040/
Abstract

This narrative review paper provides an up-to-date overview of the potential of novel synthetic and semisynthetic compounds as antibacterials that target virulence traits in resistant strains. The review focused on research conducted in the last five years and investigated a range of compounds including azoles, indoles, thiophenes, glycopeptides, pleuromutilin derivatives, lactone derivatives, and chalcones. The emergence and spread of antibiotic-resistant bacterial strains is a growing public health concern, and new approaches are urgently needed to combat this threat. One promising approach is to target virulence factors, which are essential for bacterial survival and pathogenesis, but not for bacterial growth. By targeting virulence factors, it may be possible to reduce the severity of bacterial infections without promoting the development of resistance. We discuss the mechanisms of action of the various compounds investigated and their potential as antibacterials. The review highlights the potential of targeting virulence factors as a promising strategy to combat antibiotic resistance and suggests that further research is needed to identify new compounds and optimize their efficacy. The findings of this review suggest that novel synthetic and semisynthetic compounds that target virulence factors have great potential as antibacterials in the fight against antibiotic resistance.

摘要

这篇叙述性综述论文提供了关于新型合成和半合成化合物作为针对耐药菌株毒力特征的抗菌剂潜力的最新概述。该综述聚焦于过去五年进行的研究,并研究了一系列化合物,包括唑类、吲哚类、噻吩类、糖肽类、截短侧耳素衍生物、内酯衍生物和查耳酮类。抗生素耐药细菌菌株的出现和传播是一个日益严重的公共卫生问题,迫切需要新的方法来应对这一威胁。一种有前景的方法是针对毒力因子,毒力因子对细菌的生存和发病机制至关重要,但对细菌生长并非必需。通过针对毒力因子,有可能在不促进耐药性发展的情况下降低细菌感染的严重程度。我们讨论了所研究的各种化合物的作用机制及其作为抗菌剂的潜力。该综述强调了针对毒力因子作为对抗抗生素耐药性的一种有前景策略的潜力,并表明需要进一步研究以鉴定新化合物并优化其疗效。这篇综述的结果表明,针对毒力因子的新型合成和半合成化合物在对抗抗生素耐药性方面具有作为抗菌剂的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/dd98eea0b3a2/antibiotics-12-00963-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/bdb09c92977f/antibiotics-12-00963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/25dde0419e1f/antibiotics-12-00963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/69a89e4cd2a1/antibiotics-12-00963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/90db0a9f6da5/antibiotics-12-00963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/e506cfe30e7c/antibiotics-12-00963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/a689bdfc62fa/antibiotics-12-00963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/30b7da9889d4/antibiotics-12-00963-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/912357cd4312/antibiotics-12-00963-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/aa5f7be2fda4/antibiotics-12-00963-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/a1dea929272f/antibiotics-12-00963-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/44b1ccb598eb/antibiotics-12-00963-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/5b6efa6736c2/antibiotics-12-00963-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/5a77f753f285/antibiotics-12-00963-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/8a34cf730cde/antibiotics-12-00963-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/c570f160b14d/antibiotics-12-00963-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/dd98eea0b3a2/antibiotics-12-00963-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/bdb09c92977f/antibiotics-12-00963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/25dde0419e1f/antibiotics-12-00963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/69a89e4cd2a1/antibiotics-12-00963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/90db0a9f6da5/antibiotics-12-00963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/e506cfe30e7c/antibiotics-12-00963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/a689bdfc62fa/antibiotics-12-00963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/30b7da9889d4/antibiotics-12-00963-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/912357cd4312/antibiotics-12-00963-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/aa5f7be2fda4/antibiotics-12-00963-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/a1dea929272f/antibiotics-12-00963-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/44b1ccb598eb/antibiotics-12-00963-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/5b6efa6736c2/antibiotics-12-00963-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/5a77f753f285/antibiotics-12-00963-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/8a34cf730cde/antibiotics-12-00963-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/c570f160b14d/antibiotics-12-00963-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ee/10295040/dd98eea0b3a2/antibiotics-12-00963-g016.jpg

相似文献

1
Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review.靶向耐药菌株毒力特性的合成及半合成抗菌化合物:一篇叙述性更新综述
Antibiotics (Basel). 2023 May 25;12(6):963. doi: 10.3390/antibiotics12060963.
2
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.近年来半合成糖肽类抗生素的研究进展:2014-2022 年。
ACS Infect Dis. 2022 Aug 12;8(8):1381-1407. doi: 10.1021/acsinfecdis.2c00253. Epub 2022 Jul 27.
3
Glycopeptide antibiotics and their novel semi-synthetic derivatives.糖肽类抗生素及其新型半合成衍生物。
Curr Pharm Biotechnol. 2011 Aug;12(8):1194-204. doi: 10.2174/138920111796117382.
4
Virulence factors and quorum sensing as targets of new therapeutic options by plant-derived compounds against bacterial infections caused by human and animal pathogens.植物源化合物作为新型治疗选择的靶点,针对人兽病原体引起的细菌感染的毒力因子和群体感应
Vet World. 2023 Jun;16(6):1346-1355. doi: 10.14202/vetworld.2023.1346-1355. Epub 2023 Jun 14.
5
Novel inhibitors that target bacterial virulence identified via HTS against intra-macrophage survival of .通过高通量筛选针对 . 内巨噬细胞存活的细菌毒力靶点鉴定新型抑制剂
mSphere. 2023 Oct 24;8(5):e0015423. doi: 10.1128/msphere.00154-23. Epub 2023 Aug 11.
6
New strategies for antibacterial drug design: targeting non-multiplying latent bacteria.抗菌药物设计的新策略:靶向非增殖性潜伏细菌。
Drugs R D. 2006;7(3):133-51. doi: 10.2165/00126839-200607030-00001.
7
Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic.利福霉素:一种有前途的新型截短侧耳素类抗生素的综述。
Pharmacotherapy. 2018 Sep;38(9):935-946. doi: 10.1002/phar.2166. Epub 2018 Aug 20.
8
The Very First Modification of Pleuromutilin and Lefamulin by Photoinitiated Radical Addition Reactions-Synthesis and Antibacterial Studies.通过光引发自由基加成反应对截短侧耳素和乐伐莫林进行的首次修饰——合成与抗菌研究
Pharmaceutics. 2021 Nov 28;13(12):2028. doi: 10.3390/pharmaceutics13122028.
9
[The history of the development and changes of quinolone antibacterial agents].[喹诺酮类抗菌药物的发展与变迁史]
Yakushigaku Zasshi. 2003;38(2):161-79.
10
Targeting virulence not viability in the search for future antibacterials.在寻找未来抗菌药物时,以毒力而非生存能力为靶点。
Br J Clin Pharmacol. 2015 Feb;79(2):208-15. doi: 10.1111/bcp.12356.

引用本文的文献

1
Adsorptive Removal of Amoxicillin Using Green-Synthesized SiNH@FeNP Nanocomposite: Characterization, Optimization, and Modeling.利用绿色合成的SiNH@FeNP纳米复合材料吸附去除阿莫西林:表征、优化及建模
ACS Omega. 2025 Jun 11;10(24):25951-25961. doi: 10.1021/acsomega.5c02529. eCollection 2025 Jun 24.
2
Unlocking the potential of trifluoromethyl pyrrole derivatives in chronic wounds management: rapid synthesis, structural insights, and potent antimicrobial activity.释放三氟甲基吡咯衍生物在慢性伤口管理中的潜力:快速合成、结构解析及强效抗菌活性
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2513406. doi: 10.1080/14756366.2025.2513406. Epub 2025 Jun 11.
3

本文引用的文献

1
Design and Synthesis of Novel Antimicrobial Agents.新型抗菌剂的设计与合成
Antibiotics (Basel). 2023 Mar 22;12(3):628. doi: 10.3390/antibiotics12030628.
2
Novel pyridinium cationic pleuromutilin analogues overcoming bacterial multidrug resistance.新型吡啶阳离子型截短侧耳素类似物克服细菌多重耐药性。
Eur J Med Chem. 2023 May 5;251:115269. doi: 10.1016/j.ejmech.2023.115269. Epub 2023 Mar 12.
3
Synthesis, DFT investigations, antioxidant, antibacterial activity and SAR-study of novel thiophene-2-carboxamide derivatives.
Antibacterial, antibiofilm and anti-quorum sensing activities of 1,2,3,5-tetrazine derivatives linked to a benzothiazole moiety.
与苯并噻唑部分相连的1,2,3,5-四嗪衍生物的抗菌、抗生物膜和群体感应抑制活性
PLoS One. 2025 Jun 3;20(6):e0318135. doi: 10.1371/journal.pone.0318135. eCollection 2025.
4
Metabolic engineering approaches for the biosynthesis of antibiotics.用于抗生素生物合成的代谢工程方法。
Microb Cell Fact. 2025 Jan 31;24(1):35. doi: 10.1186/s12934-024-02628-2.
5
Antibiotic Residues in Animal Products from Some African Countries and Their Possible Impact on Human Health.一些非洲国家动物产品中的抗生素残留及其对人类健康的潜在影响。
Antibiotics (Basel). 2025 Jan 14;14(1):90. doi: 10.3390/antibiotics14010090.
6
Integration of In Vitro and In Silico Results From Chemical and Biological Assays of and Flower Extracts.玫瑰和菊花提取物化学与生物学分析的体外和计算机模拟结果整合
Food Sci Nutr. 2024 Dec 19;13(1):e4663. doi: 10.1002/fsn3.4663. eCollection 2025 Jan.
7
Synthesis and antibacterial action of 3',6'-disubstituted spectinomycins.3',6'-二取代壮观霉素的合成及抗菌作用。
J Antibiot (Tokyo). 2024 Sep;77(9):577-588. doi: 10.1038/s41429-024-00750-2. Epub 2024 Jun 18.
8
Chemical Analysis and Investigation of Antimicrobial and Antibiofilm Activities of (Apiaceae).(伞形科植物)的抗菌及抗生物膜活性的化学分析与研究
Antibiotics (Basel). 2024 Jan 1;13(1):41. doi: 10.3390/antibiotics13010041.
9
Changes in the Ultrastructure of Cells Make It Possible to Identify and Analyze the Injuring Effects of Ciprofloxacin, Polycationic Amphiphile and Their Hybrid.细胞超微结构的变化使得鉴定和分析环丙沙星、聚阳离子两亲物及其混合物的损伤作用成为可能。
Microorganisms. 2023 Aug 30;11(9):2192. doi: 10.3390/microorganisms11092192.
10
Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review.非精神活性植物大麻素作为开发新型抗生素的有前景分子的合成途径:综述
Pharmaceutics. 2023 Jul 5;15(7):1889. doi: 10.3390/pharmaceutics15071889.
新型噻吩-2-甲酰胺衍生物的合成、密度泛函理论研究、抗氧化、抗菌活性及构效关系研究
BMC Chem. 2023 Feb 20;17(1):6. doi: 10.1186/s13065-023-00917-2.
4
Anti-Virulence Strategy of Novel Dehydroabietic Acid Derivatives: Design, Synthesis, and Antibacterial Evaluation.新型去氢枞酸衍生物的抗毒力策略:设计、合成与抗菌评价。
Int J Mol Sci. 2023 Feb 2;24(3):2897. doi: 10.3390/ijms24032897.
5
Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review.达巴万星治疗革兰阳性菌感染性心内膜炎的序贯治疗:综述。
Int J Antimicrob Agents. 2023 Apr;61(4):106749. doi: 10.1016/j.ijantimicag.2023.106749. Epub 2023 Feb 8.
6
Self-association of the glycopeptide antibiotic teicoplanin A2 in aqueous solution studied by molecular hydrodynamics.采用分子流体力学研究糖肽类抗生素替考拉宁 A2 在水溶液中的自缔合作用。
Sci Rep. 2023 Feb 3;13(1):1969. doi: 10.1038/s41598-023-28740-8.
7
Antibiotic resistance and drug modification: Synthesis, characterization and bioactivity of newly modified potent pleuromutilin derivatives with a substituted piperazine moiety.抗生素耐药性与药物修饰:含取代哌嗪基片段的新型强效截短侧耳素衍生物的合成、表征与生物活性。
Bioorg Chem. 2023 Mar;132:106353. doi: 10.1016/j.bioorg.2023.106353. Epub 2023 Jan 11.
8
Antimicrobial Activity of Lactones.内酯的抗菌活性。
Antibiotics (Basel). 2022 Sep 29;11(10):1327. doi: 10.3390/antibiotics11101327.
9
The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies.细菌耐药机制及潜在抑菌策略
Antibiotics (Basel). 2022 Sep 8;11(9):1215. doi: 10.3390/antibiotics11091215.
10
Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌从医院食品中分离:流行和抗菌药物耐药模式。
Curr Microbiol. 2022 Sep 20;79(11):326. doi: 10.1007/s00284-022-03022-0.